前列康品牌怎么样 申请店铺

我要投票 前列康在中草药行业中的票数:1019 更新时间:2026-02-18
前列康是哪个国家的品牌?「前列康」是 浙江康恩贝制药股份有限公司 旗下著名品牌。该品牌发源于浙江,由创始人胡季强在1993-01-09期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力前列康品牌出海!将品牌入驻外推网,定制前列康品牌推广信息,可以显著提高前列康产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

前列康怎么样

“前列康”作为江康恩贝制药股份有限公司主导植物药产品,已成国内中药前列腺治疗领域领先品牌,并荣获“中国驰名商标”荣誉。

康恩贝前列康®,是中国第一个纯花粉制剂,第一个对前列腺疾病具有治养结合的药物。列康®的花粉中富含植物生长素(EA-10)、阿魏酸γ—丁二胺(P5)、黄酮类化合物、微量元素Zn2+、Mn2+等。EA-10有着抗雄性激素、抗炎症的作用;P5主要能缩小前列腺体积、松弛平滑肌、扩张尿道等功效;氨基酸、微量元素等对于前列腺的日常保养有着积极作用。上市27年,距今未发现严重不良反应报道。

对慢性前列腺炎的急性症状,前列康®可与消炎药及镇痛药联用;对BPH的急性症状,可与α受体抑制剂联用,能更快更安全。

前列康®为国家基本药物目录品种、中药保护品种、国家医保品种,日平均治疗费约2.6元钱,价格实惠,一个月为一疗程、坚持服用疗效好。彻底摆脱夜尿、尿频、尿急、尿不尽、等排尿困难症状。

浙江康恩贝制药股份有限公司为国家火炬计划重点高新技术企业、国家创新型企业、国家知识产权试点企业、国家中药五十强企业、科技部中药现代化科技产业基地先进单位、浙江省“五个一批”重点骨干企业、浙江省专利示范企业、浙江省创新型示范企业,建有国家认定企业技术中心、国家博士后科研工作站、浙江省中药制药技术重点实验室、省级研发中心和技术中心,是浙江省首批重点企业技术创新团队。公司拥有一支由博士、硕士和高、中级职称的技术人员组成的实力雄厚、专注于现代植物药和特色化学药研发的团队,与国内外知名科研机构、大专院校建立了长期的战略合作伙伴和战略联盟,已建立新药研发的多个技术平台,通过聘请行业权威人士组成研发专家委员会,在心脑血管系统用药、泌尿系统用药、抗糖尿病用药、呼吸道系统用药、消化系统用药和抗感染药等药物的研发,以及植物提取分离和结构改造、新型药物释放系统应用等诸多方面,以现代植物药、特色化学药和保健食品发展为主线,研发具有自主知识产权的新药,在药材种植、原料药和植物提取、新药研发、制剂生产、市场营销等各环节,已建立起规范高效的产业体系。
公司自成立之日起就以市场为导向,建立起了“聚焦、扁平、高效”的营销网络体系,并全力拓展国际市场,已培育出了“前列康”、“天保宁”、“可达灵”、“刻停片”等植物药品牌以及“阿乐欣”、“金奥康”等化学药知名产品品牌,在同类竞争产品中已树立起了较具领导优势的市场地位。

公司历来十分重视产品品牌和企业品牌的培育和保护,在泌尿系统及心脑血管系统等多个领域树立了较为强势的品牌,如今,公司已成为浙江省拥有著名商标和名牌产品最多的企业之一。其中,“康恩贝”、“前列康”被认定为中国驰名商标,“天保宁”作为中国第一个符合国际质量标准的现代植物药制剂,已成为中国银杏叶制剂第一品牌;“可达灵”属国家中药保护独家品种,是公司又一个心脑血管领域的战略性品牌。此外,“金康”、“金奥康”、“贝贝”、“元邦”等均在各自领域拥有较高的品牌知名度。

展望未来,公司将秉承“集天下才智,创宏伟事业,为人类健康、献至诚至爱”的企业宗旨,倡导并培育公司和谐与激情并进的文化氛围,一如既往地致力于现代植物药领域的创新发展,发扬“艰苦创业、开拓进取、团结拼搏、创新发展、追求卓越”的康恩贝精神,发挥公司整体实力和品牌优势,在推进中药现代化、国际化的进程中,致力于将康恩贝打造成中国最具品牌价值的医药企业之一和世界植物药领军企业!

As the leading plant medicine product of jiangkang enbe Pharmaceutical Co., Ltd., "QianLieKang" has become a leading brand in the field of traditional Chinese medicine prostate treatment, and won the honor of "China famous brand". Kangenbeiqianliekang ®, the first pure pollen preparation in China, is the first drug with a combination of treatment and nutrition for prostate diseases. The pollen of Likang is rich in plant auxin (EA-10), ferulic acid γ - butanediamine (P5), flavonoids, trace elements Zn2 +, Mn2 +, etc. EA-10 has the effect of anti androgen and anti-inflammatory; P5 can reduce the volume of prostate, relax smooth muscle, dilate urethra, etc.; amino acids, trace elements, etc. have a positive effect on the daily maintenance of prostate. No serious adverse reactions have been reported since 27 years of listing. For the acute symptoms of chronic prostatitis, QianLieKang can be combined with anti-inflammatory drugs and analgesics; for the acute symptoms of BPH, QianLieKang can be combined with α receptor inhibitors, which is faster and safer. QianLieKang (QianLieKang) is a national essential drug catalog, traditional Chinese medicine protection and national medical insurance variety, with an average daily treatment cost of about 2.6 yuan, affordable price, one month as a course of treatment and good therapeutic effect. Thoroughly get rid of the night urine, frequency of urination, urgency of urination, endless urination, and other dysuria symptoms. Zhejiang Kangenbei Pharmaceutical Co., Ltd. is a key high-tech enterprise of the national torch plan, a national innovative enterprise, a national intellectual property pilot enterprise, a top 50 enterprise of the national traditional Chinese medicine, an advanced unit of the modern science and technology industrial base of traditional Chinese medicine of the Ministry of science and technology, a "five in one batch" key backbone enterprise of Zhejiang Province, a patent demonstration enterprise of Zhejiang Province, and an innovative demonstration enterprise of Zhejiang Province The state recognized enterprise technology center, National Postdoctoral research workstation, Zhejiang Key Laboratory of traditional Chinese medicine pharmaceutical technology, provincial R & D center and technology center are the first batch of key enterprise technology innovation teams in Zhejiang Province. The company has a strong team composed of doctors, masters and technicians with senior and intermediate professional titles, which focuses on the research and development of modern plant medicine and characteristic chemical medicine. It has established long-term strategic partners and strategic alliances with well-known scientific research institutions and colleges at home and abroad. It has established multiple technical platforms for new drug research and development, and has hired industry authorities to form research and development experts The committee, in many aspects such as the research and development of drugs for cardiovascular and cerebrovascular system, urinary system, anti diabetes, respiratory system, digestive system and anti infection, as well as the application of plant extraction, separation and structural transformation, and new drug release system, takes the development of modern plant medicine, characteristic chemical medicine and health food as the main line, and researches and develops products with independent knowledge A standardized and efficient industrial system has been established for the development of new drugs, including the cultivation of medicinal materials, the extraction of APIs and plants, the research and development of new drugs, the production of preparations, and marketing. Since its establishment, the company has been guided by the market, established a "focused, flat and efficient" marketing network system, and made great efforts to expand the international market. It has cultivated "QianLieKang", "Tianbaoning", "Daling", "keting tablet" and other plant medicine brands, as well as "alexin", "jinaokang" and other famous chemical product brands, which have been established in similar competitive products It has established a leading market position. The company has always attached great importance to the cultivation and protection of product brand and enterprise brand, and has established a relatively strong brand in many fields such as urinary system and cardiovascular and cerebrovascular system. Now, the company has become one of the enterprises with the most famous trademarks and famous brand products in Zhejiang Province. Among them, "Kangenbei" and "QianLieKang" are recognized as China's well-known trademarks, "Tianbaoning", as China's first modern botanical drug preparation meeting the international quality standards, has become the first brand of Ginkgo biloba preparations in China; "reachable" is the exclusive variety of national traditional Chinese medicine protection, and is another strategic brand in the cardio cerebrovascular field of the company. In addition, "Jinkang", "jinaokang", "Beibei" and "Yuanbang" have high brand awareness in their respective fields. Looking forward to the future, the company will adhere to the enterprise tenet of "gathering the wisdom of the world, creating a grand cause, contributing to human health and sincere love", advocate and cultivate a harmonious and passionate cultural atmosphere of the company, as always, commit to the innovation and development in the field of modern plant medicine, and carry forward the conerby spirit of "hard work, pioneering, unity and hard work, innovation and development, and pursuit of excellence" In the process of promoting the modernization and internationalization of traditional Chinese medicine, we are committed to building Kangenbei into one of the most famous pharmaceutical enterprises in China and the world leader in plant medicine!

本文链接: https://brand.waitui.com/cc5d91b4b.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

联合利华与谷歌云达成五年合作

联合利华与谷歌云达成五年合作,将使用谷歌云的先进人工智能、数据及平台服务。(新浪财经)

2小时前

今起对加拿大英国持普通护照者免签

为进一步便利中外人员往来,今天(2月17日)起,我国对加拿大、英国持普通护照人员实施免签政策。两国持普通护照人员来华经商、旅游观光、探亲访友、交流访问、过境不超过30天,可免办签证入境。相关免签政策实施至今年12月31日。(CCTV国际时讯)

2小时前

春节假期前两天,绿色、智能、健康类消费需求旺盛

商务大数据显示,假期前两天,全国重点零售和餐饮企业日均销售额较2025年春节前两天增长10.6%。2月15日,商务部重点监测的78个步行街(商圈)客流量、营业额比去年假期第一天分别增长23.2%、33.2%。以旧换新充分释放消费需求。截至2月16日,2026年消费品以旧换新惠及2755.6万人次,带动销售额1930.9亿元。其中,汽车以旧换新60.7万辆,带动新车销售额995.6亿元。绿色、智能、健康消费需求旺盛。商务大数据显示,2月15日,重点平台智能穿戴设备销售额增长1.3倍,智能血压仪、血糖仪增长超60%,有机食品增长52%。(央视新闻)

2小时前

阿达尼计划投资千亿美元建数据中心

阿达尼集团计划至2035年投资1000亿美元,开发由绿色能源驱动的人工智能数据中心,显示亿万富翁Gautam Adani旨在抓住印度作为人工智能与云计算中心崛起的机遇。集团旗舰企业阿达尼企业有限公司在周二的公告中表示,这笔投资可能在未来十年“催化”额外1500亿美元投入,涵盖服务器制造、先进电力基础设施及相关行业。(新浪财经)

2小时前

华纳兄弟考虑重启收购谈判,派拉蒙股价走高

据报道,在哥伦比亚广播公司母公司派拉蒙修改报价后,华纳兄弟探索公司正考虑重启收购谈判,受此消息影响,派拉蒙天舞公司股价在盘前交易中上涨2.8%。知情人士透露,华纳兄弟董事会成员正在讨论派拉蒙是否能给出更优方案,此举可能再度引发与奈飞的竞购战。奈飞股价在盘前交易中下跌0.5%,华纳兄弟股价上涨0.9%。(新浪财经)

2小时前

本页详细列出关于前列康的品牌信息,含品牌所属公司介绍,前列康所处行业的品牌地位及优势。
咨询